MSB 3.10% $2.19 mesoblast limited

MSB's proposed heart treatment product is allogeneic, which has...

  1. 265 Posts.
    lightbulb Created with Sketch. 60
    MSB's proposed heart treatment product is allogeneic, which has a clear advantage over autologous based treatments...as per the company with the recent phased IIB trial success.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$2.19
Change
-0.070(3.10%)
Mkt cap ! $1.420B
Open High Low Value Volume
$2.27 $2.27 $2.19 $3.081M 1.392M

Buyers (Bids)

No. Vol. Price($)
10 49266 $2.18
 

Sellers (Offers)

Price($) Vol. No.
$2.20 87234 9
View Market Depth
Last trade - 16.10pm 23/06/2021 (20 minute delay) ?
(live)
Last
$2.19
  Change
-0.070 ( 3.14 %)
Open High Low Volume
$2.25 $2.26 $2.19 345497
Last updated 15.59pm 23/06/2021 (live) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.